BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23249752)

  • 1. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.
    Bak RO; Hollensen AK; Primo MN; Sørensen CD; Mikkelsen JG
    RNA; 2013 Feb; 19(2):280-93. PubMed ID: 23249752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors.
    Hollensen AK; Bak RO; Haslund D; Mikkelsen JG
    RNA Biol; 2013 Mar; 10(3):406-14. PubMed ID: 23324610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges.
    Hollensen AK; Thomsen R; Bak RO; Petersen CC; Ermegaard ER; Aagaard L; Damgaard CK; Mikkelsen JG
    RNA; 2017 Aug; 23(8):1247-1258. PubMed ID: 28487381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA accessibility impacts potency of Tough Decoy microRNA inhibitors.
    Hooykaas MJG; Soppe JA; De Buhr HM; Kruse E; Wiertz EJHJ; Lebbink RJ
    RNA Biol; 2018; 15(11):1410-1419. PubMed ID: 30339041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgene-Like Animal Models Using Intronic MicroRNAs.
    Lin SL; Chang SE; Ying SY
    Methods Mol Biol; 2018; 1733():239-254. PubMed ID: 29435938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Tailored MicroRNA Sponge Activity of RNA Pol II-Transcribed TuD Hairpins Relative to Ectopically Expressed ciRS7-Derived circRNAs.
    Hollensen AK; Andersen S; Hjorth K; Bak RO; Hansen TB; Kjems J; Aagaard L; Damgaard CK; Mikkelsen JG
    Mol Ther Nucleic Acids; 2018 Dec; 13():365-375. PubMed ID: 30347350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA genes are transcribed by RNA polymerase II.
    Lee Y; Kim M; Han J; Yeom KH; Lee S; Baek SH; Kim VN
    EMBO J; 2004 Oct; 23(20):4051-60. PubMed ID: 15372072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells.
    Haraguchi T; Ozaki Y; Iba H
    Nucleic Acids Res; 2009 Apr; 37(6):e43. PubMed ID: 19223327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition.
    Qiu H; Zhong J; Luo L; Liu N; Kang K; Qu J; Peng W; Gou D
    PLoS One; 2015; 10(12):e0143864. PubMed ID: 26624995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a microRNA expression vector for function analysis of microRNA.
    Furukawa N; Sakurai F; Katayama K; Seki N; Kawabata K; Mizuguchi H
    J Control Release; 2011 Feb; 150(1):94-101. PubMed ID: 21146569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tough Decoy-Mediated Cardiac Gene Suppression.
    Kho C
    Methods Mol Biol; 2022; 2573():13-30. PubMed ID: 36040583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Efficient miRNA Inhibitors Using Tough Decoy Constructs.
    Yoo J; Hajjar RJ; Jeong D
    Methods Mol Biol; 2017; 1521():41-53. PubMed ID: 27910040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing microRNAs with vector-encoded decoy-type inhibitors.
    Bak RO; Hollensen AK; Mikkelsen JG
    Mol Ther; 2013 Aug; 21(8):1478-85. PubMed ID: 23752312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgene-like animal models using intronic microRNAs.
    Lin SL; Chang SJ; Ying SY
    Methods Mol Biol; 2006; 342():321-34. PubMed ID: 16957386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells.
    Tay FC; Lim JK; Zhu H; Hin LC; Wang S
    Adv Drug Deliv Rev; 2015 Jan; 81():117-27. PubMed ID: 24859534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100.
    Maczuga P; Koornneef A; Borel F; Petry H; van Deventer S; Ritsema T; Konstantinova P
    BMC Biotechnol; 2012 Jul; 12():42. PubMed ID: 22827812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures.
    Haraguchi T; Nakano H; Tagawa T; Ohki T; Ueno Y; Yoshida T; Iba H
    Nucleic Acids Res; 2012 Apr; 40(8):e58. PubMed ID: 22259037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
    Huang H; Zhang C; Wang B; Wang F; Pei B; Cheng C; Yang W; Zhao Z
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgene-like animal models using intronic microRNAs.
    Lin SL; Chang SJ; Ying SY
    Methods Mol Biol; 2013; 936():279-94. PubMed ID: 23007516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.